Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Focus On Cancer Immunotherapy Results
Seeking Alpha
Saturday, January 25, 2014 - 10:58am
tags:
cancer immunotherapy, ImmunoCellular Therapeutics, ICT-107, DCVax®-L, Northwest Biotherapeutics
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit on Behalf of Investors of Aegerion Pharmaceuticals, Inc.
Yahoo/BusinessWire
Saturday, January 25, 2014 - 10:55am
tags:
Aegerion, lawsuits
Amgen Inc’s Next Blockbuster Drug Delivers
Motley Fool
Saturday, January 25, 2014 - 10:54am
tags:
Amgen, AMG 145, hypercholesterolemia, cholesterol
Is There A Rally Ahead For Healthcare Stocks After Bristol Meyers Beat Earnings?
The Street
Saturday, January 25, 2014 - 10:52am
tags:
Ariad shares jump nearly 30% on rumors of Big Pharma takeover
Marketwatch
Friday, January 24, 2014 - 6:01pm
tags:
Ariad Pharmaceuticals, M&A, Eli Lilly, GSK, Shire
GSK wants collaborative approach to data sharing
PM Live
Friday, January 24, 2014 - 12:16pm
tags:
GSK, clinical trial data
GSK says melanoma combination meets main goal
Reuters
Friday, January 24, 2014 - 12:15pm
tags:
GSK, Tafinlar, Mekinist, melanoma
Cubist Pharma Misses on Earnings, Sales Strong
Yahoo/Zacks.com
Friday, January 24, 2014 - 12:11pm
tags:
earnings, Cubist Pharma
Prana Biotechnology Faces Major Upcoming Catalysts
Wall St Cheat Sheet
Friday, January 24, 2014 - 12:11pm
tags:
Prana Biotechnology, PBT2, Huntington's disease, Alzheimer's disease, brain cancer, Parkinson's Disease, PBT434, PBT519
Provectus Still Won't Answer Key Questions About Skin Cancer Drug PV-10
TheStreet.com
Friday, January 24, 2014 - 12:08pm
tags:
Provectus, PV-10, metastatic melanoma
Bristol-Myers sees 'encouraging' trends for Eliquis with hopes of expansion
Yahoo/Fly on the Wall
Friday, January 24, 2014 - 11:20am
tags:
Bristol-Myers Squibb, Eliquis, non-small cell lung cancer
Do Patent Expirations Mean Fewer Jobs At Novartis?
Wall St Cheat Sheet
Friday, January 24, 2014 - 11:19am
tags:
patents, Novartis
Neuralstem, StemCells, Inc., And Athersys, Inc. - Making Early Headlines In 2014
Seeking Alpha
Friday, January 24, 2014 - 10:19am
tags:
Neuralstem, StemCells, stem cells, Athersys
Court rules in favor of Covidien in Ethicon patent infringement lawsuit
Yahoo/Reuters
Friday, January 24, 2014 - 10:17am
tags:
patents, Covidien, Ethicon, devices, Sonicision
Shire Successfully Completes Tender Offer for ViroPharma
Yahoo
Friday, January 24, 2014 - 9:38am
tags:
ViroPharma, Shire, M&A
GSK diabetes drug set for European approval
Yahoo/Reuters
Friday, January 24, 2014 - 9:36am
tags:
GSK, diabetes, Europe, Eperzan, albiglutide, GLP-1 agonist
Intuitive Surgical Tops on Q4 Earnings & Revs
Yahoo/Zacks.com
Friday, January 24, 2014 - 9:35am
tags:
Intuitive Surgical, earnings, devices
With Iclusig back to market, would Eli Lilly bid for Ariad? Would anyone?
Fierce Pharma
Friday, January 24, 2014 - 9:12am
tags:
Iclusig, M&A, Ariad Pharmaceuticals, Eli Lilly
Merck's RNAi Trash is Alnylam's Treasure
Motley Fool
Friday, January 24, 2014 - 9:10am
tags:
Merck, RNAi, Alnylam, patents
Bayer Wins EU Panel Backing for Lung Drug After FDA Approval
Bloomberg
Friday, January 24, 2014 - 9:08am
tags:
Bayer, Europe, FDA, Adempas, pulmonary hypertension

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.